Persistent herpes gestationis treated with high-dose intravenous immunoglobulin [10]

Acta Dermato-Venereologica

Volumn 87, Issue 2, 2007, Pages 184-186

  Dos Santos Rodrigues, Carla ^a   Filipe, Paulo ^a   Del Mar Solana, Maria ^a   Soares De Almeida, Luis ^a   Cirne De Castro, José ^a   Marques Gomes, Manuel ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DAPSONE; IMMUNOGLOBULIN; PREDNISONE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HLA TYPING; HUMAN; IMMUNOFLUORESCENCE; LETTER; PEMPHIGOID GESTATIONIS; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AZATHIOPRINE; DAPSONE; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PEMPHIGOID GESTATIONIS; PREGNANCY;

EID: 34047140385     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0209     Document Type: Letter

References (13)

1. Scott JE, Ahmed AR. The blistering diseases. Med Clin North Am 1998; 82: 1239-1283.
2. Jordan RE, editor. Atlas of bullous disease. Philadelphia: Churchill Livingstone, 2000.
3. Shornick J, Black M. Secondary autoimmune diseases in herpes gestationis (Pemphigoid gestationis). J Am Acad Dermatol 1992; 26: 563-566.
4. Chimanovitch I, Schmidt E, Messer G, Dopp R, Partscht K, Brocker EB, et al. IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis. J Invest Dermatol 1999; 113: 140-142.
5. Shornick JK, Jenkins RE, Artlett CM, Briggs DC, Welsh KI, Kelly SE, et al. Class II MHC typing in pemphigoid gestationis. Clin Exp Dermatol 1995; 20: 123-126.
6. Hern S, Harman K, Bhogal BS, Black MM. A severe persistent case of phemphigoid gestationis treated with intravenous immunoglobulins and cyclosporine. Clin Exp Dermatol 1998, 23: 185-188.
7. Van de Wiel A, Hart HC, Flinterman J, Kerckhaert JA, Du Boeuff JA, Imhof JW. Plasma exchange in herpes gestationis. BMJ 1980; 281: 1041-1042.
8. Kreuter A, Harati A, Breuckmann F, Appelhans C, Altmeyer P. Intravenous immune globulin in the treatment of persistent pemphigoid gestationis. J Am Acad Dermatol 2004; 51: 1027-1028.
9. Jenkins RE, Vaughan Jones SA, Black MM. Conversion of pemphigoid gestationis to bullous phemphigoid - two refractory cases highlighting this association. Br J Dermatol 1996; 135: 595-598.
10. Shornick JK, Stastny P, Gilliam JN. High frequency of histocompatibility antigens HLA D3 and DR4 in herpes gestationis. J Clin Invest 1981; 68: 553-555.
11. Boulinguez S, Bedane C, Prost C, Bernard P, Labbe L, Bonnetblanc JM. Chronic pemphigoid gestationis: comparative clinical and immunopathological study of 10 patients. Dermatology 2003; 206: 113-119.
12. Jolles S. A review of high-dose intravenous immunoglobulin (hdlVIg) in the treatment of the autoimmune blistering disorders. Clin Exp Dermatol 2000; 26: 127-131.
13. Harman KE, Black MM. High-dose intravenous immunoglobulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Br J Dermatol 1999; 140: 865-874.